Antibiotic Resistance Pattern of Pathogens Isolated from Clinical Specimens of a Hematology-Oncology Hospital, Ahvaz, 2016-17
,
Abstract
Background: Resistance to antibiotics exists around the world. In patients with various types of cancer and also in patients undergoing bone marrow transplantation, infections and febrile neutropenia can be very dangerous. Administration of intravenous ceftazidime alone or in combination with other antibiotics is one of the first empirical treatment regimens. The present study was carried out to determine the resistance pattern of various gram – and gram + microorganisms to different antibiotics at shafa hospital in Ahvaz.
Method: This retrospective descriptive cross-sectional study was conducted for a period of one year including all referral clinical specimens from patients with malignancies to Shafa Hospital's Microbiology Laboratory. Isolated bacteria were tested for sensitive antibiotics used in clinics, especially ceftazidime, using a disc diffusion method.
Results: After reviewing the records of all patients with malignancies admitted to Shafa hospital from July 2016 toJuly 2017, 310 patients had a recorded culture result (438 cultures in total). The patients were between 1 -85 years old (mean ± SD: 29.96±24.63 years). 50.64% of the patients were male and 49.35% female, mostly admitted to emergency pediatric hematology ward(25.806%). The most common type of malignancy was acute lymphoblastic leukemia(27.096%).Pseudomonasaeroginosa was the most commonisolated pathogen (34.0182%). Only 63 positive cultures containing pseudomonas were tested for antimicrobial resistance, and among these cultures, 55.55% were resistant and 42.85% were sensitive to ceftazidime. Among 9 isolated E.coli cultures, 66.6% were resistant and 33.33% were sensitive to ceftazidime.For Acintobacter and Staph epidermidis, only1 positive culture (out of 33 and 34 respectively) was tested,and in both cases was resistant to ceftazidime.
Conclusion: Pseudomonas was the most common pathogen among isolated pathogensand about 56% of positive cultures were resistant or had intermediate sensitivity. Itseems that ceftazidime empiric therapy of infections in patients with malignancies atHematology-Oncology hospital might face high resistance.
Amiri P, Pournajaf A, Shavalipour A, Tayebi Z, Goudarzi H, Eslami G, et al. Evaluation of Antimicrobial Resistance in the BetalactamaseProducing Escherichia Coli Isolated from Urinary Tract Infection in thePatients Referring to Taleghani Hospital of Tehran. Tabari Journal ofPreventive Medicine. 2015;1(2):11-9.
Berliner N. Approach to the adult with unexplained neutropenia.UpToDate. Waltham,MA: UpToDate; 2017.
Coates TD. Overview of neutropenia in children and adolescents. In: ERichard Stiehm WCM, editor. UpToDate. Waltham,MA: UpToDate;2017.
Eric Bow JRW. Overview of neutropenic fever syndromes. In: Marr KA,editor. UpToDate. Waltham,MA2017.
Koda-Kimble M YB. Prevention and Treatment of infections inNeutropenic Cancer Patients. In: Drew RH, editor.Applied Therapeutics.10 ed. philadelphia(USA): Lippincott Williams and Wilkins; (2013). pp.1675
Wingard JR. Treatment of neutropenic fever syndromes in adultswith hematologic malignancies and hematopoietic cell transplantrecipients(high-risk patients). In: Marr KA, editor. UpToDate.Waltham,MA: UpToDate; 2017.
BowE.Treatmentandpreventionofneutropenicfeversyndromesinadultcancer patients at low risk complications. In: Marr KA, editor. UpToDate.Waltham,MA:UpToDate;2017.
Terzah M Horton CPS. Overview of the presentation and diagnosis ofacute lymphoblastic leukemia inchildren and adolescents. In: Park JR,editor. UpToDate. Waltham,MA: UpToDate; 2017.
Terzah M Horton CPS. Overview of the treatment of acute lymphoblasticleukemia in children and adolescents. In: Park JR, editor. UpToDate.Waltham,MA: UpToDate; 2017..
Charles A Schiffer JA. Clinical manifestations,pathologic features,anddiagnosis of acute myeloid leukemia. In: Larson RA, editor. UpToDate.Waltham,MA: UpToDate; 2017.
Rains CP, Bryson HM, Peters DH. Ceftazidime. Drugs. 1995;49(4):577-617.
Kathy Moscou KS. Treatment Of Bacterial Infection. Pharmacology forpharmacy technicians. 2 ed: Elsevier Mosby; (2012). p. 605.
Ceftazidime: Drug information. UpToDate. Waltham,MA: UpToDate;2017.
Davies J, Davies D. Origins and evolution of antibiotic resistance.Microbiol Mol Biol Rev. 2010;74(3):417-33.
HarbarthS.microbialresistancetoantibiotics.In:FelissaR.LashleyJDDeditor.EmergingInfectiousDiseases2.ed.NewYork:springerPublishingCompany,LLC;(2007).pp.25-47.
Hess DR. Retrospective studies and chart reviews. Res Care.2004;49(10):1171-4.
J.G.R.Howie. Doing Research. Research In General Practice. 2ed. GreatBritain: Chapman and Hall; 1989. pp. 67.
Beyar-Katz O, Dickstein Y, Borok S, Vidal L, Leibovici L, Paul M.Empirical antibiotics targeting gram-positive bacteria for the treatmentof febrile neutropenic patients with cancer. Cochrane Database SystRev. 2014;(1):CD003914.
Özdemir ZC, Koç A, Ayçiçek A. Microorganisms isolated from culturesand infection focus and antibiotic treatments in febrile neutropenicchildren from Şanlıurfa, Turkey. Turk J Pediatr 2016;58(1):47-53.
Moghnieh R, Estaitieh N, Mugharbil A, et al. Third generationcephalosporin resistant Enterobacteriaceae and multidrug resistantgram-negative bacteria causing bacteremia in febrile neutropenia adultcancer patients in Lebanon, broad spectrum antibiotics use as a majorrisk factor, and correlation with poor prognosis. Front Cell InfectMicrobiol 2015;5:11.
Castagnola E, Caviglia I, Pescetto L, Bagnasco F, Haupt R, BandettiniR. Antibiotic susceptibility of Gram-negatives isolated from bacteremiain children with cancer. Implications for empirical therapy of febrileneutropenia. Future Microbiol 2015;10(3):357-65.
Trecarichi EM, Tumbarello M. Antimicrobial-resistant Gram-negativebacteria in febrile neutropenic patients with cancer: current epidemiologyand clinical impact. Curr Opin Infect Dis 2014;27(2):200-10.
Özdemir ZC, Koç A, Ayçiçek A. Microorganisms isolated from culturesand infection focus and antibiotic treatments in febrile neutropenicchildren from Şanlıurfa, Turkey. Turk J Pediatr 2016;58(1):47-53.
Sirkhazi M, Sarriff A, Aziz NA, Almana F, Arafat O, Shorman M.Bacterial Spectrum, Isolation Sites and Susceptibility Patterns ofPathogens in Adult Febrile Neutropenic Cancer Patients at a SpecialistHospital in Saudi Arabia. World J Oncol 2014;5(5):196-203
Lakshmaiah KC, Malabagi AS, Govindbabu RS, Sinha M, JayashreeRS. Febrile neutropenia in hematological malignancies: clinicalndmicrobiologicalprofileandoutcomeinhighriskpatients.JLabPhysicians2015;7(2):116-120.
| Files | ||
| Issue | Vol 5, No 3-4 (Winter 2017) | |
| Section | Original Article(s) | |
| Keywords | ||
| Anti-BacterialAgents Antibacterial Drug Resistance Cancer Neutropeia | ||
| Rights and permissions | |
|
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
